Widely available lysosome targeting agents should be considered as potential therapy for COVID-19

•Lysosome targeting agents can disrupt endolysosomal maturation and inhibit viral replication•Lysosome targeting agents and lysosomotropic drugs should be explored as antiviral drugs for severe acute respiratory syndrome coronavirus-2•Some lysosomotropic drugs are commonly used pharmacological agent...

Ausführliche Beschreibung